SCHEMBL3373569

SCHEMBL3373569

CCS(=O)(=O)Oc1cccc(C(=O)O)c1C(=O)NC(C)(C)CSC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALOX15 P16050 1/20 0.35
CA12 O43570 4/20 0.33
CA9 Q16790 4/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 2/20 0.32
FABP4 P15090 3/20 0.31
FABP3 P05413 1/20 0.31
FABP5 Q01469 1/20 0.31
KMT2A Q03164 3/20 0.31
MEN1 O00255 2/20 0.31
RECQL P46063 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373572 0.91 NPSR1 (0.43) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL2891984 0.90 NPSR1 (0.39) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL3377632 0.88 NPSR1 (0.37) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL3377686 0.86 NPSR1 (0.40) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL2891988 0.81 NPSR1 (0.41) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL3377879 0.80 MEN1 (0.39) NPSR1L3MBTL1CA12CA9ALDH1A1
SCHEMBL550826 0.79 NPSR1 (0.52) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL3377641 0.79 NPSR1 (0.40) NPSR1L3MBTL1ALOX15CA12CA9
SCHEMBL3377959 0.79 MEN1 (0.39) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL551442 0.77 FABP4 (0.37) NPSR1L3MBTL1ALOX15CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 NPSR1 918/4885L3MBTL1 1720/4885ALOX15 4156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.